Please login to the form below

interferon beta-1a

This page shows the latest interferon beta-1a news and features for those working in and with pharma, biotech and healthcare.

Positive COPD data for Synairgen's SNG001 supports COVID-19 programme

placebo. SNG001 delivers an inhaled formulation of Interferon-beta-1a (INF-beta-1a) to the lungs directly via nebulisation and has previously been tested in phase 2 trials in asthma. ... INF-beta is a naturally occurring protein that controls the

Latest news

UK biotech Synairgen reveals promising early results for COVID-19 drug

SNG001 delivers an inhaled formulation of Interferon-beta-1a (INF-beta-1a) to the lungs directly via nebulisation and has previously been tested in phase 2 trials in asthma. ... The results confirm our belief that interferon-beta, a widely known drug that
Trump calls on FDA to cut ‘red tape’ as coronavirus drug trials gather pace

Finally, Merck KGaA has donated a supply of its interferon beta-1a product Rebif – approved for multiple sclerosis - to France’s INSERM research organisation following a request for use in a
UK biotech Synairgen to begin COVID-19 trial of lead candidate

SNG001 (inhaled formulation of interferon-beta-1a), as concerns grow in the UK that COVID-19 cases could soar in the comings weeks. ... Interferon-beta (IFN-beta) is a naturally occurring protein that controls the body’s antiviral responses.
Ocrevus off to a flying start as Roche raises 2017 forecasts

The take-up of the drug has been buoyed by trials showing that the drug outperformed Merck KGaA's MS stalwart Rebif (interferon beta-1a) in two relapsing MS phase III
Roche sets disruptive price for new MS drug Ocrevus in US

Ocrevus' clinical profile has already caught the attention of MS patients and their doctors, with trials showing that the drug outperformed Merck KGaA's Rebif (interferon beta-1a) in two relapsing

More from news
Approximately 1 fully matching, plus 54 partially matching documents found.

Latest Intelligence

Tackling a formidable foe

Formidable foe. “With Rebif (interferon beta-1a), Merck’s legacy MS therapy approved in Europe 20 years ago, one of the innovations is the ability to have auto-injectors and devices

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping: Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much: Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website: You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...